Jennifer L. Good, President and CEO of Trevi Therapeutics, Inc. ($TRVI), made one open market sale of common shares in the last 365 days, totaling about $35,000. Her most recent sale occurred on March 21, 2025. These sales rank 10,701st among 11,678 individual insiders, compared to an average sale amount of $8.6 million across 6.4 transactions on average. Good made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | A | Stock Option (right to buy) | 675000 | $0.00 | 675,000.0000 | 145,104,986 | 9999.99% | 0.47% |
| June 24, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | A | Stock Option (right to buy) | 7037 | $0.00 | 7,037.0000 | 63,059,165 | 9999.99% | 0.01% |
| June 24, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | A | Restricted Stock Units | 4712 | $0.00 | 4,712.0000 | 63,059,165 | 9999.99% | 0.01% |
| June 18, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 4000 | $0.00 | 7,000.0000 | 63,059,165 | 133.33% | 0.01% |
| June 18, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Restricted Stock Units | 4000 | $0.00 | 0.0000 | 63,059,165 | 100.00% | 0.01% |
| May 31, 2025 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | A | Performance Stock Option (right to buy) | 102000 | $0.00 | 156,400.0000 | 101,971,873 | 187.50% | 0.10% |
| March 21, 2025 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 5263 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 0.01% |
| March 21, 2025 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 5263 | $1.43 | 218,576.0000 | 101,971,873 | 2.47% | 0.01% |
| March 21, 2025 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 5263 | $6.58 | 213,313.0000 | 101,971,873 | 2.41% | 0.01% |
| March 10, 2025 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | A | Performance Stock Option (right to buy) | 54400 | $0.00 | 54,400.0000 | 101,971,873 | 9999.99% | 0.05% |
| Feb. 18, 2025 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | A | Stock Option (right to buy) | 811000 | $0.00 | 811,000.0000 | 101,971,873 | 9999.99% | 0.80% |
| Sept. 17, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | S | Common Stock | 31751 | $52.40 | 3,000.0000 | 61,011,824 | 91.37% | 0.05% |
| Sept. 17, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 7501 | $18.99 | 34,751.0000 | 61,011,824 | 27.53% | 0.01% |
| Sept. 17, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 9250 | $21.37 | 27,250.0000 | 61,011,824 | 51.39% | 0.02% |
| Sept. 17, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 15000 | $22.93 | 18,000.0000 | 61,011,824 | 500.00% | 0.02% |
| Sept. 17, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 9250 | $0.00 | 0.0000 | 61,011,824 | 100.00% | 0.02% |
| Sept. 17, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 7501 | $0.00 | 0.0000 | 61,011,824 | 100.00% | 0.01% |
| Sept. 17, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 15000 | $0.00 | 0.0000 | 61,011,824 | 100.00% | 0.02% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 18300 | $0.00 | 0.0000 | 61,011,824 | 100.00% | 0.03% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 12900 | $22.93 | 15,900.0000 | 61,011,824 | 430.00% | 0.02% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 4305 | $21.37 | 20,205.0000 | 61,011,824 | 27.08% | 0.01% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 1736 | $18.99 | 21,941.0000 | 61,011,824 | 8.59% | 0.00% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 18300 | $4.15 | 40,241.0000 | 61,011,824 | 83.41% | 0.03% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | S | Common Stock | 37241 | $50.45 | 3,000.0000 | 61,011,824 | 92.54% | 0.06% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 12900 | $0.00 | 15,000.0000 | 61,011,824 | 46.24% | 0.02% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 4305 | $0.00 | 9,250.0000 | 61,011,824 | 31.76% | 0.01% |
| Sept. 9, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 1736 | $0.00 | 7,501.0000 | 61,011,824 | 18.79% | 0.00% |
| Sept. 6, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 4219 | $0.00 | 1,840.0000 | 99,033,373 | 69.63% | 0.00% |
| Sept. 9, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 1840 | $3.04 | 213,313.0000 | 99,033,373 | 0.86% | 0.00% |
| Sept. 9, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 1840 | $1.43 | 215,153.0000 | 99,033,373 | 0.86% | 0.00% |
| Sept. 9, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 1840 | $0.00 | 0.0000 | 99,033,373 | 100.00% | 0.00% |
| Sept. 6, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 4219 | $3.03 | 213,313.0000 | 99,033,373 | 1.94% | 0.00% |
| Sept. 6, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 4219 | $1.43 | 217,532.0000 | 99,033,373 | 1.98% | 0.00% |
| Sept. 3, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 3863 | $3.02 | 213,313.0000 | 99,033,373 | 1.78% | 0.00% |
| Sept. 5, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 40277 | $1.43 | 253,590.0000 | 99,033,373 | 18.88% | 0.04% |
| Sept. 4, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 10981 | $0.00 | 46,336.0000 | 99,033,373 | 19.16% | 0.01% |
| Sept. 3, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 3863 | $1.43 | 217,176.0000 | 99,033,373 | 1.81% | 0.00% |
| Sept. 5, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 40277 | $0.00 | 6,059.0000 | 99,033,373 | 86.92% | 0.04% |
| Sept. 3, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 3863 | $0.00 | 57,317.0000 | 99,033,373 | 6.31% | 0.00% |
| Sept. 5, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 40277 | $3.11 | 213,313.0000 | 99,033,373 | 15.88% | 0.04% |
| Sept. 4, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 10981 | $3.02 | 213,313.0000 | 99,033,373 | 4.90% | 0.01% |
| Sept. 4, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 10981 | $1.43 | 224,294.0000 | 99,033,373 | 5.15% | 0.01% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 2100 | $0.00 | 27,900.0000 | 61,011,824 | 7.00% | 0.00% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 4945 | $0.00 | 13,555.0000 | 61,011,824 | 26.73% | 0.01% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 1700 | $0.00 | 18,300.0000 | 61,011,824 | 8.50% | 0.00% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Stock Option (right to buy) | 5763 | $0.00 | 9,237.0000 | 61,011,824 | 38.42% | 0.01% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 1700 | $4.15 | 17,508.0000 | 61,011,824 | 10.75% | 0.00% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | S | Common Stock | 14508 | $50.01 | 3,000.0000 | 61,011,824 | 82.86% | 0.02% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 2100 | $22.93 | 5,100.0000 | 61,011,824 | 70.00% | 0.00% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 4945 | $21.37 | 10,045.0000 | 61,011,824 | 96.96% | 0.01% |
| Aug. 26, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 5763 | $18.99 | 15,808.0000 | 61,011,824 | 57.37% | 0.01% |
| June 21, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Restricted Stock Units | 3000 | $0.00 | 0.0000 | 60,143,558 | 100.00% | 0.00% |
| June 21, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | M | Common Stock | 3000 | $0.00 | 3,000.0000 | 60,143,558 | 9999.99% | 0.00% |
| June 18, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 60,143,558 | 9999.99% | 0.02% |
| June 18, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | A | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 60,143,558 | 9999.99% | 0.01% |
| May 20, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 25037 | $2.19 | 238,350.0000 | 99,033,373 | 11.74% | 0.03% |
| May 20, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 25037 | $0.00 | 33,189.0000 | 99,033,373 | 43.00% | 0.03% |
| May 20, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 25037 | $2.86 | 213,313.0000 | 99,033,373 | 10.50% | 0.03% |
| May 10, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 4578 | $0.00 | 58,226.0000 | 99,033,373 | 7.29% | 0.00% |
| May 10, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | M | Common Stock | 4578 | $2.19 | 217,891.0000 | 99,033,373 | 2.15% | 0.00% |
| May 10, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | S | Common Stock | 4578 | $2.90 | 213,313.0000 | 99,033,373 | 2.10% | 0.00% |
| Feb. 15, 2024 | Trevi Therapeutics, Inc. | $TRVI | GOOD JENNIFER L | President & CEO | A | Stock Option (right to buy) | 630000 | $0.00 | 630,000.0000 | 99,033,373 | 9999.99% | 0.64% |
| June 21, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | A | Restricted Stock Units | 3000 | $0.00 | 3,000.0000 | 56,708,975 | 9999.99% | 0.01% |
| June 21, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | GOOD JENNIFER L | Director | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 56,708,975 | 9999.99% | 0.02% |